Instrument Inactif

Communiqués ProstaLund AB

Actions

PLUN

SE0023468418

Equipement, fournitures et distribution médicale

Communiqués

24/10/25	PROSTALUND AB (publ) - Interim report January-September 2025	AQ
12/09/25	ProstaLund enters collaboration agreement with the XEN Group for the market in the United Arab Emirates and Oman	AQ
10/09/25	ProstaLund enters collaboration agreement with Mayumana Healthcare for the Benelux market	AQ
21/08/25	ProstaLund AB - Interim Report January-June 2025	AQ
26/06/25	First CoreTherm® Eagle treatments performed in Denmark	AQ
17/06/25	Second clinic in Sweden starts treatment with CoreTherm® Eagle	AQ
30/05/25	ProstaLund AB - Interim report January-March 2025	AQ
20/05/25	First patients treated with CoreTherm® Eagle	AQ
14/05/25	First treatments with CoreTherm® Eagle to be performed next week – Key milestone for ProstaLund	AQ
20/02/25	ProstaLund AB - Year-end report 2024	AQ
10/12/24	Additional study published confirming effectiveness of transurethral intraprostatic anaesthesia (TUIA) using our Schelin Catheter® during benign prostatic enlargement treatments	AQ
07/11/24	The first ten CoreTherm® Eagle machines are manufactured	AQ
11/10/24	Short-term results and long-term durability after CoreTherm® treatments presented at the Emirates International Urological Conference in Dubai, UAE	AQ
04/10/24	First published report of transurethral intraprostatic anaesthesia (TUIA) using the Schelin Catheter® in patients undergoing holmium laser enucleation of the prostate	AQ
12/09/24	Published study confirming effectiveness of transurethral intraprostatic anaesthesia (TUIA) using our Schelin Catheter®	AQ
19/08/24	First patients treated with CoreTherm® Concept in Austria	AQ
19/08/24	ProstaLund AB - Interim report January-June 2024	AQ
24/06/24	New agreement - Aarhus in Denmark starts up with CoreTherm® treatments	AQ
31/05/24	New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria	AQ
16/05/24	ProstaLund AB - Interim report January-March 2024	AQ
12/04/24	ProstaLund hosted unannounced audit by TÜV SÜD	AQ
08/04/24	Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	AQ
27/02/24	Schelin Catheter® - new study confirms efficiency and ease of use	AQ
16/02/24	Year-end report – ProstaLund AB (publ)	AQ
12/12/23	New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	AQ